Optical tissue‑fingerprinting platform providing real‑time, highly specific differentiation of healthy vs tumor tissue via a handheld SmartScan for ex vivo analysis during surgery. Targets surgical teams and pathology workflows (e.g., breast‑conserving procedures) to improve surgical accuracy, reduce residual tumor and replace slow diagnostics; clinical studies report ≥90% sensitivity and >85% specificity/accuracy.